WordNet

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 心不全におけるナトリウム利尿ペプチド測定 natriuretic peptide measurement in heart failure
2. 非心不全下におけるナトリウム利尿ペプチド測定 natriuretic peptide measurement in non heart failure settings
3. 心血管疾患の危険因子の概要 overview of the possible risk factors for cardiovascular disease
4. 乳幼児および小児における心不全の病因および診断 etiology and diagnosis of heart failure in infants and children
5. 心不全が疑われる患者の評価 evaluation of the patient with suspected heart failure

Association of N-Terminal Pro-B-Type Natriuretic Peptide With Left Ventricular Structure and Function in Chronic Kidney Disease (from the Chronic Renal Insufficiency Cohort [CRIC]).

Mishra RK, Li Y, Ricardo AC, Yang W, Keane M, Cuevas M, Christenson R, Defilippi C, Chen J, He J, Kallem RR, Raj DS, Schelling JR, Wright J, Go AS, Shlipak MG; Chronic Renal Insufficiency Cohort Investigators.SourceUniversity of California, San Francisco, San Francisco, California; San Francisco Veterans Affairs Medical Center, San Francisco, California. Electronic address: rakesh.mishra@ucsf.edu.
The American journal of cardiology.Am J Cardiol.2013 Feb 1;111(3):432-8. doi: 10.1016/j.amjcard.2012.10.019. Epub 2012 Nov 22.
We evaluated the cross-sectional associations of N-terminal pro-B-type natriuretic peptide (NT-proBNP) with cardiac structural and functional abnormalities in a cohort of patients with chronic kidney disease without clinical heart failure, the Chronic Renal Insufficiency Cohort (n = 3,232). The ass
PMID 23178053

Troponin T, B-type natriuretic peptide, C-reactive protein, and cause-specific mortality.

Oluleye OW, Folsom AR, Nambi V, Lutsey PL, Ballantyne CM; ARIC Study Investigators.SourceDivision of Epidemiology and Community Health, University of Minnesota School of Public Health, Minneapolis, MN.
Annals of epidemiology.Ann Epidemiol.2013 Feb;23(2):66-73. doi: 10.1016/j.annepidem.2012.11.004. Epub 2012 Dec 8.
PURPOSE: We sought to evaluate the associations of high-sensitivity troponin T (Hs-TnT), N-terminal pro-brain natriuretic peptide (NT-proBNP), and high sensitivity C-reactive protein (Hs-CRP) with mortality from any cause, cardiovascular disease (CVD), coronary heart disease (CHD), stroke, cancer, a
PMID 23228375

Multicenter, Randomized, Double-Blinded, Placebo-Controlled Phase II Study of Serelaxin in Japanese Patients With Acute Heart Failure

, , , , , , , , , , , , ,
Circulation Journal advpub(0), 2015
… A greater reduction in NT-proBNP was noted with serelaxin (–50.8% and –54.9% for 10 and 30 µg·kg–1·day–1, respectively at Day 2).Conclusions:Serelaxin was well tolerated in this study with Japanese AHF patients, with no AEs of concern and favorable beneficial trends on efficacy. …
NAID 130005066294

Predicting Short-Term Mortality in Advanced Decompensated Heart Failure　– Role of the Updated Acute Decompensated Heart Failure/N-Terminal Pro-B-Type Natriuretic Peptide Risk Score –

, , , , , , , , , , , , ,
Circulation Journal 79(5), 1076-1083, 2015
… Background:The first few months after admission are the most vulnerable period in patients with acute decompensated heart failure (ADHF).Methods and Results:We assessed the association of the updated ADHF/N-terminal pro-B-type natriuretic peptide (NT-proBNP) risk score with 90-day and in-hospital mortality in 701 patients admitted with advanced ADHF, defined as severe symptoms of worsening HF, severely depressed left ventricular ejection fraction, and the need for i.v. …
NAID 130005066255

Predicting Short-Term Mortality in Advanced Decompensated Heart Failure:– Role of the Updated Acute Decompensated Heart Failure/N-Terminal Pro-B-Type Natriuretic Peptide Risk Score –

, , , , , , , , , , , , ,
Circulation Journal advpub(0), 2015
… Background:The first few months after admission are the most vulnerable period in patients with acute decompensated heart failure (ADHF).Methods and Results:We assessed the association of the updated ADHF/N-terminal pro-B-type natriuretic peptide (NT-proBNP) risk score with 90-day and in-hospital mortality in 701 patients admitted with advanced ADHF, defined as severe symptoms of worsening HF, severely depressed left ventricular ejection fraction, and the need for i.v. …
NAID 130004927227

参考1

	心不全の可能性はきわめて低い	心不全の可能性は低いが、可能ならば経過観察	軽度の心不全の可能性があるので精査、経過観察	治療対象となる心不全の可能性有り精査 or 専門医紹介	治療対象となる心不全の可能性高精査 or 専門医紹介
BNP	0～18.4	18.4～40	40～100	100～200	200～
NT-proBNP	0～125		125～400	400～900	900～